| Product Name | MF | CAS | Details |
|---|
| [4-(2-Fluorophenoxy)phenyl]methanamine | C13H12FNO | 864263-02-5 | Details |
| 1-Isopropyl-3-(4-fluorophenyl)indole | C17H16FN | 93957-49-4 | Details |
| 5,6-Dimethoxynicotinic acid | C8H9NO4 | 76470-34-3 | Details |
| Vercirnon sodium | C22H20ClN2NaO4S | 886214-18-2 | Details |
| H-TPP-OH | Details |
| 2-Methyl-4-oxocyclohexane-1-carboxylic acid | C8H12O3 | 115989-20-3 | Details |
| Calcitonin, humanAntiserum | Details |
| XL-784 | C21H22ClF2N3O8S | 1224964-36-6 | Details |
| Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione | C7H5N3O2 | 21038-67-5 | Details |
| THAP6 antibody | Details |
| [(1R,2R,3R,4S,7R,9S,10S,11R,12R,15S)-2,4,9,11,12-Pentaacetyloxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-1 3-en-15-yl] acetate | C32H44O13 | 57672-78-3 | Details |
| LDN-192960 dihydrochloride | C18H20N2O2S | 184582-62-5 | Details |
| 2-Chloroethanesulfonyl fluoride | C2H4ClFO2S | 762-70-9 | Details |
| 1-Cyclopentyl-5-ethyl-1H-pyrazol-4-amine | C10H17N3 | 1506443-80-6 | Details |
| 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid | C12H11NO2 | 124730-56-9 | Details |
| 3-Methyl-1-(1-{5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}ethyl)-1H-pyrazol-4-amine hydrochloride | C13H21ClN6 | 1431966-49-2 | Details |
| (Pyridin-3-ylmethyl)phosphonic acid | C6H8NO3P | 74095-34-4 | Details |
| 1-[(Benzyloxy)carbonyl]-3-(carboxymethyl)pyrrolidine-3-carboxylic acid | C15H17NO6 | 1384430-43-6 | Details |
| 4-(Piperidin-1-yl)pyridine-2-carbonitrile | C11H13N3 | 127680-88-0 | Details |
| 3-Amino-N,N-diethylpropanamide | C7H16N2O | 71274-45-8 | Details |
| 5H,6H,7H,8H-Imidazo[1,2-a]pyrazin-8-one | C6H7N3O | 740082-70-6 | Details |
| PCDHB13 Blocking Peptide | Details |
| 2,6-Dichlorophenol | C6H4Cl2O | 87-65-0 | Details |
| 5,7-Difluoro-3-iodo-1-(phenylsulfonyl)-1H-indole | C14H8F2INO2S | 500139-01-5 | Details |
| 4-Methyl-1,2,3-thiadiazole-5-carboxamide | C4H5N3OS | 175136-67-1 | Details |
| Columbianadin | C19H20O5 | 5058-13-9 | Details |
| (1s,3s)-3-[2-(tert-butoxy)-2-oxoethyl]cyclobutane-1-carboxylic acid, cis | C11H18O4 | 847416-52-8 | Details |
| 4-Bromo-5-(chlorosulfonyl)thiophene-2-carboxylic acid | C5H2BrClO4S2 | 1306604-23-8 | Details |
| 5-Hydroxy-7,8,2'-trimethoxyflavone | C18H16O6 | 1165-40-8 | Details |
| H-LEKHGAITS-OH | Details |
| SLITRK1 Blocking Peptide | Details |
| Methyl α-L-rhamnopyranoside | C7H14O5 | 14917-55-6 | Details |
| 2-(1H-1,2,4-Triazol-1-yl)butanoic acid | C6H9N3O2 | 1157990-31-2 | Details |
| 2-Bromo-3-chloronitrobenzene | C6H3BrClNO2 | 19128-48-4 | Details |
| 2'-Hydroxypropiophenone | C9H10O2 | 610-99-1 | Details |
| C-myc antibody (HRP) | Details |
| 7-o-Acetylbonducellpin C | C25H34O8 | 197781-86-5 | Details |
| {[(3-Bromopropyl)sulfanyl]methyl}benzene | C10H13BrS | 88738-51-6 | Details |
| 6-Methylisobenzofuran-1(3H)-one | C9H8O2 | 72985-23-0 | Details |
| 2-(5-Bromopentyl)-1,3-dioxolane | C8H15BrO2 | 56741-68-5 | Details |
| MAOB Blocking Peptide | Details |
| (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one | C21H28O2 | 100021-05-4 | Details |
| [(2,3,4-Trimethoxyphenyl)methyl]hydrazine dihydrochloride | C10H18Cl2N2O3 | 1258650-11-1 | Details |
| SR9009 | C20H24ClN3O4S | 1379686-30-2 | Details |
| Ubl3 Blocking Peptide | Details |
| N,N'-Bis[3-acetyl-4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-urea | C31H46N4O7 | 125579-40-0 | Details |
| THPP-1 | C23H21ClN6O3 | 1257051-63-0 | Details |
| SARS-CoV-2 Spike RBD 513-520 peptide | Details |
| 9-Hydroxy-alpha-lapachone | C15H14O4 | 22333-58-0 | Details |
| Methyl 5-hydroxypentanoate | C6H12O3 | 14273-92-8 | Details |
| RB1 antibody | Details |
| 1-(Chloromethyl)-4-[(difluoromethyl)sulfanyl]benzene | C8H7ClF2S | 1221723-34-7 | Details |
| 3-Fluoro-4-formylbenzoic acid | C8H5FO3 | 193290-80-1 | Details |
| MK 0893 | C32H27Cl2N3O4 | 870823-12-4 | Details |
| N,N-Dimethyl decanamide | C12H25NO | 14433-76-2 | Details |
| H-KRYFKLSHLQMHSRKH-OH | Details |
| proBNP antibody (biotin) | Details |
| Dihydrotestosterone ELISA Kit | Details |
| 3-[(4-Fluorophenyl)methyl]-1,2,4-oxadiazol-5-ol | C9H7FN2O2 | 1251317-25-5 | Details |
| 3-Amino-7-bromo-1-benzothiophene-2-carboxylic acid | C9H6BrNO2S | 1780193-19-2 | Details |
| Ethyl 2-oxo-2-(1H-pyrrol-2-yl)acetate | C8H9NO3 | 27472-43-1 | Details |
| 3-Deoxy-1,2-O-O-isopropylidene-3-trifluoromethyl-a-D-glucofuranose | C10H15F3O5 | Details |
| 3-Methyl-2-phenylazetidine | C10H13N | 1354958-21-6 | Details |
| 4-Isocyanato-1H-indole | C9H6N2O | 581812-74-0 | Details |
| 1-Methyl-2-(pyrrolidin-2-yl)-1H-1,3-benzodiazole dihydrochloride | C12H17Cl2N3 | 1193389-65-9 | Details |
| N-[(Oxan-4-yl)methyl]cyclobutanamine hydrochloride | C10H19NO.ClH | 2260936-89-6 | Details |
| 5-(2-Oxopropyl)pyrrolidin-2-one | C7H11NO2 | 1369104-14-2 | Details |
| 1-Amino-3-(thiophene-2-sulfonyl)propan-2-ol | C7H11NO3S2 | 1082500-83-1 | Details |
| Adenosine 2',3'-O-phenylboronate | C16H16BN5O4 | 4710-68-3 | Details |
| Trimethylsilyl-meso-inositol | C24H60O6Si6 | 2582-79-8 | Details |
| NXF5 Blocking Peptide | Details |
| 1-(Pyridazin-4-yl)propan-1-one | C7H8N2O | 66645-87-2 | Details |
| tert-Butyl 3-azabicyclo[3.1.0]hexane-3-carboxylate | C10H17NO2 | 936551-50-7 | Details |
| 1-(Azepan-1-yl)-2-(piperazin-1-yl)propan-1-one | C13H25N3O | 90476-97-4 | Details |
| Methyl 1-methyl-4-oxopiperidine-2-carboxylate | C8H13NO3 | 86251-51-6 | Details |
| H-VAIDAGYR-OH | Details |
| Phenyl α-D-galactopyranoside | C12H16O6 | 2871-15-0 | Details |
| H-RKRTLRRL-OH | Details |
| N'-(2-Chloropropanoyl)-3-methylbutanehydrazide | C8H15ClN2O2 | 1311317-45-9 | Details |
| 7-Bromo-5-methyl-1H-indazol-3-amine | C8H8BrN3 | 1388073-21-9 | Details |
| {1-[Amino(oxolan-2-yl)methyl]cyclobutyl}methanol | C10H19NO2 | 1803593-94-3 | Details |
| Methyl 2-[(5-bromopyridin-2-yl)amino]acetate | C8H9BrN2O2 | 620175-59-9 | Details |
| 3-(Chloromethyl)-5-(2-naphthalenyl)isoxazole | C14H10ClNO | 1245131-14-9 | Details |
| 5-Bromothieno[3,2-b]thiophene-2-carboxylic acid | C7H3BrO2S2 | 1378448-42-0 | Details |
| 6-Amino-1-[2-(diethylamino)ethyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione | C10H18N4O2 | 2434-44-8 | Details |
| MADS14 antibody | Details |
| 2-[1-(Methylamino)cyclohexyl]acetic acid hydrochloride | C9H18ClNO2 | 1354950-06-3 | Details |
| PYCR2 protein | Details |
| {[(2S,4S)-4-Fluoro-1-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-2-yl]methyl}(methyl)amine dihydrochloride | C9H16ClFN4O | 1807939-09-8 | Details |
| 6-Amino-1,3-dimethyl-2,4-disulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | C7H8N4S2 | 2241139-79-5 | Details |
| 4-Bromo-2-fluoro-5-(trifluoromethyl)-3-(trimethylsilyl)benzaldehyde | C11H11BrF4OSi | 2060005-95-8 | Details |
| [3-(Dimethylamino)propyl][(3-ethoxy-4-propoxyphenyl)methyl]amine dihydrochloride | C17H31ClN2O2 | 1049757-49-4 | Details |
| (2-Methoxyethoxy)benzene | C9H12O2 | 41532-81-4 | Details |
| 1-Amino-N-(cyclopropylmethyl)cyclopentane-1-carboxamide | C10H18N2O | 1183226-12-1 | Details |
| 1-(2-Methoxyphenyl)-1H-pyrazole-5-carbaldehyde | C11H10N2O2 | 1159830-34-8 | Details |
| 6'-Sialylgalactose sodium salt | C17H29NO14 | 35259-23-5 | Details |
| 2-Bromo-2-[4-(trifluoromethyl)phenyl]acetic acid | C9H6BrF3O2 | 133486-71-2 | Details |
| Ethyl 3-chloro-6-(chlorosulfonyl)-1-methyl-1H-pyrrolo[3,2-b]pyridine-2-carboxylate | C11H10Cl2N2O4S | 1423025-12-0 | Details |
| 2,2,2-Trifluoroethyl 5-chloropyridine-2-carboxylate | C8H5ClF3NO2 | 1820687-46-4 | Details |
| 5H,6H,7H,8H-Pyrido[3,4-b]pyrazine | C7H9N3 | 405162-62-1 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||